Avidity Biosciences
RNA
#1835
Rank
ยฃ8.10 B
Marketcap
ยฃ53.77
Share price
0.13%
Change (1 day)
86.02%
Change (1 year)

Revenue for Avidity Biosciences (RNA)

Revenue in 2025 (TTM): ยฃ15.66 Million

According to Avidity Biosciences's latest financial reports the company's current revenue (TTM ) is ยฃ15.66 Million. In 2024 the company made a revenue of ยฃ8.68 Million an increase over the revenue in the year 2023 that were of ยฃ7.5 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avidity Biosciences from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ15.66 M80.43%
2024 ยฃ8.68 M15.72%
2023 ยฃ7.5 M-1.58%
2022 ยฃ7.62 M10.35%
2021 ยฃ6.9 M38.76%
2020 ยฃ4.97 M181.56%
2019 ยฃ1.76 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
PTC Therapeutics
PTCT
ยฃ1.33 B 8,425.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ86.82 M 454.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.81 B 11,466.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.43 B 2,670.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
ยฃ5.35 M-65.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ84.64 M 440.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 300,772.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.79 B 202,855.61%๐Ÿ‡ฌ๐Ÿ‡ง UK